期刊文献+

α-硫辛酸、甲钴胺、前列地尔联合治疗糖尿病周围神经病变的效果 被引量:12

Effect of Alpha-lipoic Acid,Mecobalamin and Alprostadil on Diabetic Peripheral Neuropathy
下载PDF
导出
摘要 目的:探讨α-硫辛酸、甲钴胺、前列地尔联合治疗糖尿病周围神经病变的效果。方法:选择笔者所在医院2016年4月-2018年5月糖尿病周围神经病变患者100例。随机分组,对照组采取α-硫辛酸、甲钴胺治疗,观察组则采取α-硫辛酸、甲钴胺+前列地尔治疗。比较两组糖尿病周围神经病变控制率;症状改善的时间、行走功能好转的时间;治疗前后患者神经传导的平均速度、TSS总分;毒副作用。结果:观察组糖尿病周围神经病变控制率、症状改善的时间、行走功能好转的时间、神经传导的平均速度、TSS总分相比较对照组更好,差异有统计学意义(P<0.05)。观察组和对照组毒副作用相似,差异无统计学意义(P>0.05)。结论:α-硫辛酸、甲钴胺+前列地尔治疗糖尿病周围神经病变效果好。 Objective:To investigate the effect of Alpha-lipoic Acid,Mecobalamin and Alprostadil in the treatment of diabetic peripheral neuropathy. Method:From April 2016 to May 2018,100 patients with diabetic peripheral neuropathy in our hospital were selected.The control group was treated with alpha-lipoic Acid and Mecobalamin,while the observation group was treated with Alpha-lipoic Acid,Mecobalamin and Alprostadil.The control rate of diabetic peripheral neuropathy,the time of improvement of symptoms and walking function,the average speed of nerve conduction,total TSS score and toxicity and side effects were compared between the two groups.Result:Compared with the control group,the control rate of diabetic peripheral neuropathy,the improvement time of symptoms,the improvement time of walking function,the average speed of nerve conduction and the total score of TSS in the observation group were better(P<0.05).The side effects of observation group and control group were similar(P>0.05).Conclusion:Alpha-lipoic Acid,Mecobalamin and Alprostadil are effective in the treatment of diabetic peripheral neuropathy.
作者 孙秀菊 SUN Xiuju(Macheng People’s Hospital,Macheng 438300,China)
机构地区 麻城市人民医院
出处 《中外医学研究》 2019年第11期25-27,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 Α-硫辛酸 甲钴胺 前列地尔 联合治疗 糖尿病周围神经病变 效果 Alpha-lipoic Acid Mecobalamin Alprostadil Combination therapy Diabetic peripheral neuropathy Effect
  • 相关文献

二级参考文献74

  • 1凌丹芸,汤正义,王卫庆.抗氧化剂α-硫辛酸在糖尿病神经病变治疗中的作用[J].世界临床药物,2005,26(12):726-729. 被引量:12
  • 2张向东,邵红山,张锋利.前列腺素E_1、氯沙坦与弥可保合用治疗糖尿病周围神经病变的疗效[J].中国实用神经疾病杂志,2006,9(5):113-113. 被引量:9
  • 3Nasseri K,Strijers RL,Dekhuijzen LS,et al.Reproducibilityof different methods for diagnosing and monitoring diabeticneuropathy[J].Electromyogr Clin Neurophysiol,1998,38(5):295-299.
  • 4Kashyap AS,Anand KP,Kashyap S,et al.Peripheral neurop-athy[J].Lancet,2004,364(9446):1 664-1 665.
  • 5Du XL, Edelstein D, Rossetti L, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogeu activator inhibitor-1 expression by increasing Splglycosylation . Proc Natl Acad Sci US A 2000;97 (22) : 12222 - 12226.
  • 6Milder J, Patel M. Modulation of oxidative stress and mito- chondrial function by the ketogenic diet. Epilepsy Res 2012 ; 100 ( 3 ) : 295 - 303.
  • 7Sang Soo Kim,Jong Chul Won,Hyuk Sang Kwon,et al. Preva- lence and clinical implications of painful diabetic peripheral nem-opathy in type 2 diahetes: Results from a nationwide hospital-based study of diabetic neuropathy in Korea[J].Di- abetes Research and Clinical Practice,2013.
  • 8Randhir Singh,Lalit Kishore,Navpreet Kaur. Diabetic pe- ripheral neuropathy: Current perspective and tuture direc- tions[J]. Pharmacological Research,2013.
  • 9Williams MD, Nadle JL. Inflammatory mechanisms of dia - betic complications [J]. Curr Diab Rep,2007 ,7(3):242-248.
  • 10Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longi- tudinalstudy[J]. Diabetologia,2009,52:1265-1273.

共引文献147

同被引文献81

引证文献12

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部